Abstract
There are two major dynamic processes in bone: bone formation and bone resorption which determine the volume of bone and ultimately its strength. Because bone is a tissue which is continuously remodeling, bone formation is an essential part of skeletal maintenance even after the growth period where bone formation is obviously essential. Moreover, bone has a remarkable regenerative potential which enables it to remodel itself in response to changing physical demands, and to repair itself after injury. In the majority of the adult skeleton, bone formation is confined to specific remodeling sites. Whether bone is lost or gained will depend on the extent of bone formation in each one of these sites. With regard to the mediators of bone formation, growth factors have received much attention. Of the several growth factors present in bone (IGF-I, IGF-II, TGF-β1, TGF-β2, PDGF, basic FGF, acidic FGF and BMPs), there is now sufficient evidence to document an important role for the IGFs in the local regulation of bone formation. In this paper we describe the components of the IGF regulatory system and discuss evidence supporting a role for IGFs in the local regulation of bone formation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Mohan, DJ. Baylink. Bone growth factors. Clin Orthoped Rel Res 263:30(1991).
S. Mohan, DJ. Baylink. The role of insulin-like growth factor-II in the coupling of bone formation to resorption. in: “Modern Concepts of Insulin-Like Growth Factors,“ E.M. Spencer, ed., Elsevier, New York (1991).
J. Zapf, E.R. Froesch. Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm Res 24:121 (1986).
A.G. Johansson, E. Lindh, S. Ljunghall. Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet 339:1619 (1992).
S. Mohan, C.M. Bautista, J.E. Wergedal, D.J. Baylink. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action. Proc NatlAcadSci USA 86:8338 (1989).
S. Mohan, J. Dequeker, R. Van den Eyned, J. Peeters, J. Aerssens, DJ. Baylink. Increased insulin-like growth factor (IGF)-I and IGF-II in bone from patients with osteoarthritis. J Bone and Mine Res 6:S131 (1991).
V. Nicolas, A. Prewett, P. Bettica, et.al. Evidence for a progressive decline of IGF-I in human bone in both males and females as a function of age. J Bone Min Res 7:S255 (1992).
S. Mohan. Insulin-like growth factor binding proteins in bone cell regulation. Growth Regulation 3:65 (1993).
R.M. Maciel, A.C. Moses, G. Villone, D. Tramontano, S.H. Ingbar. Demonstration of the production and physiological role of insulin-like growth factor II in rat thyroid follicular cells in culture. J Clin Invest 82:1846 (1988).
A. Gray, A.W. Tam, T.J. Dull, J. Hayflick, J. Pintar, W.K. Cavenee, A. Koufos, A. Ullrich. Tissue-specific and developmentally regulated transcription of the insulin-like growth factor 2 gene. DNA 6:283 (1987).
T.L. McCarthy, M. Centrella, E. Canalis. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124:1247 (1989).
R.D. Finkelman S. Mohan, T.A. Linkhart, S.M. Abraham, J.P. Boussy, DJ. Baylink. PTH stimulates the proliferation of TE-85 human osteosarcoma cells by a mechanism not involving either increased cAMP or increased secretion of IGF-I, IGF-II or TGF beta. Bone Mineral 16:89 (1992).
S.H. Scharia, D.D. Strong, S. Mohan, D.J. Baylink, T.A. Linkhart. 1,25 dihydroxyvitamin D3 differentially regulates the production of IGF-I and IGFBP-4 in mouse osteoblasts. Endocrinology 129:3139 (1991).
R.J. Fitzsimmons, D.D. Strong, S. Mohan, D.J. Baylink. Low-amplitude, low-frequency electric field-stimulated bone cell proliferation may in part be mediated by increase IGF-II release. J Cell Physiol 150:84,1992.
F.T. Tremollieres, D.D. Strong, D.J.Baylink, S. Mohan. Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-II production. Acta Endocrinol (Copenh) 126:329 (1992).
R. Knutsen, K. Sampath, D.J. Baylink, S. Mohan. Evidence that osteogenic protein-1 (OP-1) may modulate its effects on human bone cell proliferation (HBC) by regulating the local production of insulin-like growth factors. J Bone and Min Res 7:S104 (1992).
S. Shimasaki, N. Ling. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog in Growth Factor Res 1:243 (1991).
S. Mohan, D.J. Baylink. Isolation and characterization of insulin-like growth factor binding proteins produced by human bone cells in vitro. JBone Min Res 6:S141 (1991).
C.M. Bautista, D.J. Baylink, S. Mohan. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176:756 (1991).
C. Conover. Potentiation of insulin-like growth factor (IGF) action by IGF binding protein-3: Studies of underlying mechanism. Endocrinology 130:3191 (1992).
M. Rashmi, D.D. Strong, D.J. Baylink, S. Mohan. Stimulation of human bone cell proliferation by an antisense oligodeoxyribonucleotide to IGFBP-4 mRNA. J Bone Min Res 7:S124 (1992).
P.T. Cheung, E.P. Smith, S. Shimasaki, N. Ling, S.D. Chernausek. Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by B104 rat neuronal cell line: Chemical and biological properties and differential synthesis by sublines. Endocrinology 129:1006 (1991).
J.M. Culouscou, M. Shoyab. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Cancer Res 51:2813 (1991).
D.L. Andress, R.S. Birnbaum. A novel insulin-like growth factor binding protein secreted by osteoblast-like cells. Biochem Biophys Res Commun 176:213 (1991).
D. LaTour, S. Mohan, T.A. Linkhart, D.J. Baylink, D.D. Strong. Inhibitory insulin-like growth factor binding protein: Cloning, complete sequence and physiological regulation. Molec Endocrinol 4:1806 (1990).
O. Torring, A.F. Firek, H. Heath III, C.A. Conover. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3’,5’-monophosphate-dependent mechanism. Endocrinology 128:1006 (1991).
C. Rosen, L.R. Donahue, S. Hunter, M. Holick, H. Kavookjian, A. Kirschenbaum, S. Mohan, D.J. Baylink. The 24/25 kDa serum insulinlike growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocinol Metab 74:24 (1992).
K. Lee, S. Mohan, D.J. Baylink, D.D. Strong. Evidence that transcriptional regulation of insulin-like growth factor binding protein-4 (IGFBP-4) gene in human bone cells. JBone Min Res 7:S232 (1992).
S.H. Scharia, C. Rosen, D.D. Strong, S. Mohan, D.J. Baylink, T.A. Linkhart. Stimulatory effect of l,25(OH)2D3 on IGFBP-4 secretion in bone cells. 2nd International Workshop on IGFBPs ,Opio, France (1992).
U.G. Lempert, D.D. Strong, D.J. Baylink, S. Mohan. Effects of progesterone on the mRNA levels of IGFBP-3, IGFBP-4, IGFBP-5 and IGFBP-6 in human osteoblastic cells. 2nd International Workshop on IGFBPs ,Opio, France (1992).
S. Mohan, D.D. Strong, U.G. Lempert, J.E. Wergedal, D.J. Baylink. Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells. Acta Endocinology 127:555 (1992).
U.G. Lempert, C. Bautista, D.D. Strong, D.J. Baylink, S. Mohan. Purification of a novel human bone derived inulin-like growth factor binding protein (hBD-IGFBP): A potential candidate for fixing IGF-II in bone. J Bone Min Res 6:S250 (1991).
L.C. Guidice, E.M. Farrel, H. Pham, G. Lamson, R.G. Rosenfeld. Insulin-like growth factor bidning proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity. JClin Endocrinol Metab 71:806 (1990).
P. Hossenlopp, B. Segovia, C. Lassarre, M. Roghani, M.Bredon, M. Binoux. Evidence of enzymzatic degradation of insulin-like growth factor binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab 71:797 (1990).
S. Kanzaki, Malpe R. Baylink D.J., S. Mohan. Evidence that human bone cells (HBC) in culture produce insulin-like growth factor binding protein (IGFBP)-4 and -5 proteases. 75th Annual Meeting, The Endocrine Society In Press (1993).
P.G. Campbell, J.F. Novak, T.B. Yanosick, J.H. McMaster. Involvement of the plasmin system in dissociation of the insulin-like growth factor binding protein complex. Endocrinology 130:1401 (1992).
J.R. Farley, N. Tarbaux, L.A. Murphy, T. Masuda, D.J. Baylink. In vitro evidence that bone formation may be coupled to bone resorptioon by release of mitogen(s) from resorbing bone. Metabolism 36:314 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mohan, S., Baylink, D.J. (1994). Characterization of the IGF Regulatory System in Bone. In: Le Roith, D., Raizada, M.K. (eds) Current Directions in Insulin-Like Growth Factor Research. Advances in Experimental Medicine and Biology, vol 343. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2988-0_37
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2988-0_37
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6301-9
Online ISBN: 978-1-4615-2988-0
eBook Packages: Springer Book Archive